| 11964961 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more |
2024-04-23 |
$398,665,000 |
| 11014909 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more |
2021-05-25 |
$425,301,000 |
| 10696658 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more |
2020-06-30 |
$597,435,000 |
| 10421744 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more |
2019-09-24 |
$287,330,000 |
| 10316021 |
Heteroarylphenoxy benzamide kappa opioid ligands |
Natasha Mariam Kablaoui, Justin Ian Montgomery, Michael Aaron Brodney, Patrick Robert Verhoest, Gregory Wayne Kauffman +5 more |
2019-06-11 |
$297,650,000 |
| 10093655 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more |
2018-10-09 |
$408,783,000 |
| 9850232 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
David Lawrence Firman Gray, Lei Zhang, Michael Aaron Brodney, Chakrapani Subramanyam |
2017-12-26 |
$289,207,000 |
| 9822097 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more |
2017-11-21 |
$292,923,000 |
| 9764040 |
Spliceostatin analogs and methods for their preparation |
Chakrapani Subramanyam, Frank Koehn, Kenneth John Dirico, Alessandra S. Eustaquio, Haiyin He +6 more |
2017-09-19 |
$381,523,000 |
| 9751877 |
Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders |
Martin Youngjin Pettersson, Douglas Scott Johnson, Chakrapani Subramanyam, Christopher John O'Donnell, Christopher William am Ende +6 more |
2017-09-05 |
$172,618,000 |
| 9745317 |
Heterocyclic compounds and their use as dopamine D1 ligands |
David Lawrence Firman Gray, Lei Zhang, Michael Aaron Brodney, Jennifer Elizabeth Davoren, Ivan Viktorovich Efremov +2 more |
2017-08-29 |
$222,975,000 |
| 9540352 |
Substituted 1,7-naphthyridines as dopamine D1 ligands |
David Lawrence Firman Gray, Lei Zhang, Michael Aaron Brodney, Chakrapani Subramanyam |
2017-01-10 |
$767,679,000 |
| 9527831 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more |
2016-12-27 |
$413,344,000 |
| 9504669 |
Spliceostatin analogs and methods for their preparation |
Chakrapani Subramanyam, Frank Koehn, Kenneth John Dirico, Alessandra S. Eustaquio, Haiyin He +6 more |
2016-11-29 |
$771,469,000 |
| 9193726 |
Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders |
Martin Youngjin Pettersson, Douglas Scott Johnson, Chakrapani Subramanyam, Christopher John O'Donnell, Christopher William am Ende +6 more |
2015-11-24 |
$383,549,000 |
| 9169264 |
Spliceostatin analogs and methods for their preparation |
Chakrapani Subramanyam, Frank Koehn, Kenneth John Dirico, Alessandra S. Eustaquio, Haiyin He +6 more |
2015-10-27 |
$660,560,000 |
| 9139561 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more |
2015-09-22 |
$161,915,000 |
| 9107923 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more |
2015-08-18 |
$621,732,000 |
| 9067934 |
Bicyclic pyridinones |
Martin Youngjin Pettersson, Douglas Scott Johnson, Chakrapani Subramanyam, Christopher John O'Donnell, Christopher William am Ende +5 more |
2015-06-30 |
$178,322,000 |
| 8916564 |
Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders |
Martin Youngjin Pettersson, Douglas Scott Johnson, Chakrapani Subramanyam, Christopher John O'Donnell, Christopher William am Ende +6 more |
2014-12-23 |
$289,866,000 |
| 8697673 |
Bicyclic pyridinones |
Martin Youngjin Pettersson, Douglas Scott Johnson, Chakrapani Subramanyam, Christopher John O'Donnell, Christopher William am Ende +5 more |
2014-04-15 |
$644,265,000 |
